Home › NDC Lookup › RxCUI directory › RxCUI 2569480

3 ML icatibant 10 MG/ML Prefilled Syringe [Sajazir] — RxCUI 2569480

RxNorm drug concept · Semantic branded drug
RxCUI 2569480 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2569480
Official name3 ML icatibant 10 MG/ML Prefilled Syringe [Sajazir]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asSajazir (as icatibant acetate) 30 MG per 3 ML Prefilled Syringe; Sajazir 30 MG in 3 ML Prefilled Syringe
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)68 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 3 ML icatibant 10 MG/ML Prefilled Syringe [Sajaz... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 3 ML icatibant 10 MG/ML Prefilled Syringe [Sajazir] RxCUI 2569480

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Icatibant 1148138
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Sajazir 2569476
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Icatibant Prefilled Syringe 1148140
    • Icatibant Injectable Product 1160663
    • Icatibant Prefilled Syringe [Sajazir] 2569479
    • Sajazir Injectable Product 2569478
    • Prefilled Syringe 721656
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Icatibant 10 MG/ML [Sajazir] SBDC · 2569477
  • Icatibant Prefilled Syringe [Sajazir] SBDF · 2569479
  • Sajazir Injectable Product SBDG · 2569478
  • Sajazir BN · 2569476

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2569480 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70709-0013-01 1 SYRINGE, GLASS in 1 CARTON (70709-013-01) / 3 mL in 1 SYR... SAJAZIR Cycle Pharmaceuticals Ltd-Uk 2021-06-03
70709-0013-03 3 SYRINGE, GLASS in 1 CARTON (70709-013-03) / 3 mL in 1 SYR... SAJAZIR Cycle Pharmaceuticals Ltd-Uk 2021-06-03
Observed labelers: Cycle Pharmaceuticals Ltd-Uk (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.